Uncategorized

ON A DIFFERENT NOTE–DR PHIL’S PERSONALITY TEST


After all that hardcore IP, I thought this would be a welcome change. Try Dr Phil’s test below (as forwarded in an email from one of my friends, Anil Mani, the “voice over guy“–we went to the same school and though some generations apart, he is much younger at heart than I am). I’m not sure whether I scored a 38 or a 41–as sometimes I’m on my back before I go to sleep and sometimes I’m curled up on…


Read More »
Uncategorized

ONE “FLU” OVER THE CUCKOO’S NEST: OF AN UNRELENTING ROCHE AND AN INDIAN ROBIN-HOOD


Once again, the relationship between patent rights and public health has made mainstream media –and this time, in the context of the notorious AVIAN FLU, which is spreading rapidly. A recent news item states that Roche, which holds the patent over Tamiflu is unwilling to license it, despite the fact that it cannot produce enough quantities to cater to an outbreak, should one occur. It notes: “Tamiflu, a pricey antiviral pill invented in a Bay Area lab and made in…


Read More »
Uncategorized

RANBAXY LOSES TO PFIZER IN THE UK


Certainly breaking news!! For those coming in late on this (in true Phantom style), Ranbaxy challenged Pfizer’s 10 billion anti-cholestrol dollar drug (Lipitor) patent, arguing that it was invalid. It was succesful in Austria but lost just yesterday in the UK. A decision is awaited in the US, which incidentally is the main market and where experts expect Pfizer to win (not too surprising, since the US is more pro-patent than is the UK). The UK loss is therefore a…


Read More »